Cargando…

l- to d-Amino Acid Substitution in the Immunodominant LCMV-Derived Epitope gp33 Highlights the Sensitivity of the TCR Recognition Mechanism for the MHC/Peptide Structure and Dynamics

[Image: see text] Presentation of pathogen-derived epitopes by major histocompatibility complex I (MHC-I) can lead to the activation and expansion of specific CD8(+) T cell clones, eventually resulting in the destruction of infected target cells. Altered peptide ligands (APLs), designed to elicit im...

Descripción completa

Detalles Bibliográficos
Autores principales: Ballabio, Federico, Broggini, Luca, Paissoni, Cristina, Han, Xiao, Peqini, Kaliroi, Sala, Benedetta Maria, Sun, Renhua, Sandalova, Tatyana, Barbiroli, Alberto, Achour, Adnane, Pellegrino, Sara, Ricagno, Stefano, Camilloni, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945122/
https://www.ncbi.nlm.nih.gov/pubmed/35350306
http://dx.doi.org/10.1021/acsomega.1c06964
_version_ 1784673877212790784
author Ballabio, Federico
Broggini, Luca
Paissoni, Cristina
Han, Xiao
Peqini, Kaliroi
Sala, Benedetta Maria
Sun, Renhua
Sandalova, Tatyana
Barbiroli, Alberto
Achour, Adnane
Pellegrino, Sara
Ricagno, Stefano
Camilloni, Carlo
author_facet Ballabio, Federico
Broggini, Luca
Paissoni, Cristina
Han, Xiao
Peqini, Kaliroi
Sala, Benedetta Maria
Sun, Renhua
Sandalova, Tatyana
Barbiroli, Alberto
Achour, Adnane
Pellegrino, Sara
Ricagno, Stefano
Camilloni, Carlo
author_sort Ballabio, Federico
collection PubMed
description [Image: see text] Presentation of pathogen-derived epitopes by major histocompatibility complex I (MHC-I) can lead to the activation and expansion of specific CD8(+) T cell clones, eventually resulting in the destruction of infected target cells. Altered peptide ligands (APLs), designed to elicit immunogenicity toward a wild-type peptide, may affect the overall stability of MHC-I/peptide (pMHC) complexes and modulate the recognition by T cell receptors (TCR). Previous works have demonstrated that proline substitution at position 3 (p3P) of different MHC-restricted epitopes, including the immunodominant LCMV-derived epitope gp33 and escape variants, may be an effective design strategy to increase epitope immunogenicity. These studies hypothesized that the p3P substitution increases peptide rigidity, facilitating TCR binding. Here, molecular dynamics simulations indicate that the p3P modification rigidifies the APLs in solution predisposing them for the MHC-I loading as well as once bound to H-2D(b), predisposing them for TCR binding. Our results also indicate that peptide position 6, key for interaction of H-2D(b)/gp33 with the TCR P14, takes a suboptimal conformation before as well as after binding to the TCR. Analyses of H-2D(b) in complex with APLs, in which position 6 was subjected to an l- to d-amino acid modification, revealed small conformational changes and comparable pMHC thermal stability. However, the l- to d-modification reduced significantly the binding to P14 even in the presence of the p3P modification. Our combined data highlight the sensitivity of the TCR for the conformational dynamics of pMHC and provide further tools to dissect and modulate TCR binding and immunogenicity via APLs.
format Online
Article
Text
id pubmed-8945122
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-89451222022-03-28 l- to d-Amino Acid Substitution in the Immunodominant LCMV-Derived Epitope gp33 Highlights the Sensitivity of the TCR Recognition Mechanism for the MHC/Peptide Structure and Dynamics Ballabio, Federico Broggini, Luca Paissoni, Cristina Han, Xiao Peqini, Kaliroi Sala, Benedetta Maria Sun, Renhua Sandalova, Tatyana Barbiroli, Alberto Achour, Adnane Pellegrino, Sara Ricagno, Stefano Camilloni, Carlo ACS Omega [Image: see text] Presentation of pathogen-derived epitopes by major histocompatibility complex I (MHC-I) can lead to the activation and expansion of specific CD8(+) T cell clones, eventually resulting in the destruction of infected target cells. Altered peptide ligands (APLs), designed to elicit immunogenicity toward a wild-type peptide, may affect the overall stability of MHC-I/peptide (pMHC) complexes and modulate the recognition by T cell receptors (TCR). Previous works have demonstrated that proline substitution at position 3 (p3P) of different MHC-restricted epitopes, including the immunodominant LCMV-derived epitope gp33 and escape variants, may be an effective design strategy to increase epitope immunogenicity. These studies hypothesized that the p3P substitution increases peptide rigidity, facilitating TCR binding. Here, molecular dynamics simulations indicate that the p3P modification rigidifies the APLs in solution predisposing them for the MHC-I loading as well as once bound to H-2D(b), predisposing them for TCR binding. Our results also indicate that peptide position 6, key for interaction of H-2D(b)/gp33 with the TCR P14, takes a suboptimal conformation before as well as after binding to the TCR. Analyses of H-2D(b) in complex with APLs, in which position 6 was subjected to an l- to d-amino acid modification, revealed small conformational changes and comparable pMHC thermal stability. However, the l- to d-modification reduced significantly the binding to P14 even in the presence of the p3P modification. Our combined data highlight the sensitivity of the TCR for the conformational dynamics of pMHC and provide further tools to dissect and modulate TCR binding and immunogenicity via APLs. American Chemical Society 2022-03-07 /pmc/articles/PMC8945122/ /pubmed/35350306 http://dx.doi.org/10.1021/acsomega.1c06964 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Ballabio, Federico
Broggini, Luca
Paissoni, Cristina
Han, Xiao
Peqini, Kaliroi
Sala, Benedetta Maria
Sun, Renhua
Sandalova, Tatyana
Barbiroli, Alberto
Achour, Adnane
Pellegrino, Sara
Ricagno, Stefano
Camilloni, Carlo
l- to d-Amino Acid Substitution in the Immunodominant LCMV-Derived Epitope gp33 Highlights the Sensitivity of the TCR Recognition Mechanism for the MHC/Peptide Structure and Dynamics
title l- to d-Amino Acid Substitution in the Immunodominant LCMV-Derived Epitope gp33 Highlights the Sensitivity of the TCR Recognition Mechanism for the MHC/Peptide Structure and Dynamics
title_full l- to d-Amino Acid Substitution in the Immunodominant LCMV-Derived Epitope gp33 Highlights the Sensitivity of the TCR Recognition Mechanism for the MHC/Peptide Structure and Dynamics
title_fullStr l- to d-Amino Acid Substitution in the Immunodominant LCMV-Derived Epitope gp33 Highlights the Sensitivity of the TCR Recognition Mechanism for the MHC/Peptide Structure and Dynamics
title_full_unstemmed l- to d-Amino Acid Substitution in the Immunodominant LCMV-Derived Epitope gp33 Highlights the Sensitivity of the TCR Recognition Mechanism for the MHC/Peptide Structure and Dynamics
title_short l- to d-Amino Acid Substitution in the Immunodominant LCMV-Derived Epitope gp33 Highlights the Sensitivity of the TCR Recognition Mechanism for the MHC/Peptide Structure and Dynamics
title_sort l- to d-amino acid substitution in the immunodominant lcmv-derived epitope gp33 highlights the sensitivity of the tcr recognition mechanism for the mhc/peptide structure and dynamics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945122/
https://www.ncbi.nlm.nih.gov/pubmed/35350306
http://dx.doi.org/10.1021/acsomega.1c06964
work_keys_str_mv AT ballabiofederico ltodaminoacidsubstitutionintheimmunodominantlcmvderivedepitopegp33highlightsthesensitivityofthetcrrecognitionmechanismforthemhcpeptidestructureanddynamics
AT brogginiluca ltodaminoacidsubstitutionintheimmunodominantlcmvderivedepitopegp33highlightsthesensitivityofthetcrrecognitionmechanismforthemhcpeptidestructureanddynamics
AT paissonicristina ltodaminoacidsubstitutionintheimmunodominantlcmvderivedepitopegp33highlightsthesensitivityofthetcrrecognitionmechanismforthemhcpeptidestructureanddynamics
AT hanxiao ltodaminoacidsubstitutionintheimmunodominantlcmvderivedepitopegp33highlightsthesensitivityofthetcrrecognitionmechanismforthemhcpeptidestructureanddynamics
AT peqinikaliroi ltodaminoacidsubstitutionintheimmunodominantlcmvderivedepitopegp33highlightsthesensitivityofthetcrrecognitionmechanismforthemhcpeptidestructureanddynamics
AT salabenedettamaria ltodaminoacidsubstitutionintheimmunodominantlcmvderivedepitopegp33highlightsthesensitivityofthetcrrecognitionmechanismforthemhcpeptidestructureanddynamics
AT sunrenhua ltodaminoacidsubstitutionintheimmunodominantlcmvderivedepitopegp33highlightsthesensitivityofthetcrrecognitionmechanismforthemhcpeptidestructureanddynamics
AT sandalovatatyana ltodaminoacidsubstitutionintheimmunodominantlcmvderivedepitopegp33highlightsthesensitivityofthetcrrecognitionmechanismforthemhcpeptidestructureanddynamics
AT barbirolialberto ltodaminoacidsubstitutionintheimmunodominantlcmvderivedepitopegp33highlightsthesensitivityofthetcrrecognitionmechanismforthemhcpeptidestructureanddynamics
AT achouradnane ltodaminoacidsubstitutionintheimmunodominantlcmvderivedepitopegp33highlightsthesensitivityofthetcrrecognitionmechanismforthemhcpeptidestructureanddynamics
AT pellegrinosara ltodaminoacidsubstitutionintheimmunodominantlcmvderivedepitopegp33highlightsthesensitivityofthetcrrecognitionmechanismforthemhcpeptidestructureanddynamics
AT ricagnostefano ltodaminoacidsubstitutionintheimmunodominantlcmvderivedepitopegp33highlightsthesensitivityofthetcrrecognitionmechanismforthemhcpeptidestructureanddynamics
AT camillonicarlo ltodaminoacidsubstitutionintheimmunodominantlcmvderivedepitopegp33highlightsthesensitivityofthetcrrecognitionmechanismforthemhcpeptidestructureanddynamics